Rafael Holdings (RFL) Granted Orphan Drug Designation from EMA for Devimistat (CPI-613) for Treatment of Metastatic Pancreatic Cancer - https://t.co/gM21sWkdr3 https://t.co/1qlzSXMKJD
— IDRO (@IDROOhio) January 11, 2019
from Twitter https://twitter.com/IDROOhio
January 10, 2019 at 10:01PM
No comments:
Post a Comment